Dr. Michael Cohen-Wolkowiez is the Kiser-Arena Distinguished Professor of Pediatrics at Duke University and Head of Pediatrics at the Duke Clinical Research Institute. His research focuses on methods to advance and accelerate clinical studies in children and adults as well as strategic leadership of large, federally sponsored programs and networks. In support of his research mission, he has used a diversified research portfolio that includes peer reviewed funding for which he is Principal Investigator from NIH, FDA, BARDA, foundations, and industry. Dr. Cohen-Wolkowiez worked for two years as a Scientific Advisor to the FDA and has served as protocol chair, principal investigator, or held an investigational new drug (IND) application for 15+ trials enrolling of more than 3,500 children.
Most recently, he serves as the Contact Principal Investigator for the Rapid Acceleration of Diagnostics in Underserved Populations Coordination and Data Collection Center (RADx-UP CDCC), which is the single largest investment in health disparities in the history of NIH and aims to increase access and uptake of COVID-19 tests in historically marginalized populations. He is the author of more >160 peer reviewed publications and has been supported by NIH to mentor numerous trainees.
Cohen-Wolkowiez completed his medical degree at the Universidad Central de Venezuela and his residency in Pediatrics at the Nicklaus Children’s Hospital in Miami, Florida. Board-certified in pediatrics and pediatric infectious disease, he completed infectious disease subspecialty training at Duke University and received a PhD in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill Eshelman School of Pharmacy.